LILRB2 and colorectal carcinoma: In addition to well-known and clinically proven ICIs targeting the PD-1/PD-L1 signaling pathway, it has been demonstrated using the Cox regression data that a higher ILT-4 expression could be an independent prognostic risk factor for patients with CRC.